Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of our non-vested stock option grants:

	Number of Stock Options	Weighted Average Exercise Prices		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2019	207,069	$	18.69	9.00	$	—
Granted	221,541	8.77		—	—
Less: Forfeited	159,233	12.84		—	—
Less: Exercised	—	—		—	—
Outstanding as of June 30, 2020	269,377	$	13.99	8.16	$	—
Vested as of June 30, 2020	69,027	$	18.69	4.67	$	—
Exercisable as of June 30, 2020	69,027	$	18.69	4.67	$	—

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of our non-vested common stock grants:

	Number of Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2019	214,495	$	17.49
Granted (1)	347,254	9.57
Less: Forfeited	165,102	12.95
Less: Vested (1)	104,115	16.47
Outstanding as of June 30, 2020	292,532	$	11.01

Share-based Payment Arrangement, Activity

The following table presents our total stock-based compensation expense:

	Three Months Ended June 30,					Six Months Ended June 30,
	2020			2019		2020		2019
Employee stock-based compensation expense
Pre-tax	$	(52	)	$	416	$	474	$	946
Post-tax (1)	(41		)	329		374		747
Director stock-based compensation expense
Pre-tax	133			261		307		632
Post-tax (1)	105			206		243		499

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following weighted-average assumptions were used to value the stock options granted:

	2020
Expected annual dividend yield	1.70	%
Expected volatility	41.59	%
Risk-free interest rate	2.35	%
Expected term	6 Years